We next determined if iGP-1 was cell-permeant and, therefore, potentially useful for inhibiting mGPDH in situ. Several iGPs exhibited fluorescence with excitation maxima between 320�C 360 nm and emission maxima between 360�C480 nm. Cells treated with 100 mM iGP-1 displayed fluorescence above background, with bright puncta in the buy MN-64 cytosol, low levels in the nucleus, and intermediate levels distributed diffusely within the cytosol. Timelapse imaging of iGP-1 suggested the punctate fluorescence was in rapidly moving structures independent of the mitochondrial network. Similar distribution of cellular iGP-1 fluorescence was also observed in several other cultured cell lines. Colabeling of cells with iGP-1 and LysoTracker Red DND-99, which localizes to acidic vesicles such as endosomes and lysosomes, revealed a high correlation between the most intense iGP-1 fluorescence and acidic vesicles. Treatment of cells with 250 nM bafilomycin A1, an inhibitor of vesicular ATPases, collapsed the vesicular pH gradient and also caused loss of the bright, punctate staining of iGP-1 but not the diffuse fluorescence in the cytosol. To address whether iGP-1 was accumulated in acidic vesicles or if iGP-1 fluorescence was enhanced at the lower pH of these vesicles, we measured the fluorescence of iGP-1 as a function of pH. We observed an 8-fold increase in iGP-1 fluorescence as the pH was lowered from pH 7 to pH 1.5. Further, addition of the protonophore FCCP to cells caused a rapid, though BMN 195 incomplete, loss of the bright, punctate staining seen with iGP-1 alone. Together, these data suggest that the intense punctate staining of iGP-1 is likely the result of a pH-dependent enhancement of iGP-1 fluorescence in acidic compartments and not accumulation in vesicles. Importantly, we can conclude that iGP-1 readily crosses cellular membranes and therefore should have access to mGPDH in intact systems. We then applied iGP-1 alone or in combination with aminooxyacetate in synaptosomes respiring on glucose. Maximal demand was created by adding FCCP. In control experiments, pyruvate replaced glucose to bypass the need for NAD + regeneration. 100 mM iGP-1, 0.5 mM aminooxyacetate, or their combination had no effect on basal or maximal respiration with pyruvate. With glucos